Lassa Fever Vaccine

About Medigen

Medigen is a preclinical-stage biotech company developing a pipeline of vaccines for significant unmet medical needs, including Chikungunya, Venezuelan Equine Encephalitis (VEE), Lassa fever, and influenza. Its strategy is built on a proprietary vaccine technology platform designed to elicit safe and robust immune responses. The company is expanding its physical footprint for manufacturing and R&D, indicating a transition towards clinical development and potential contract manufacturing capabilities. As a private entity with no marketed products, it remains in a pre-revenue, R&D-intensive phase.

Therapeutic Areas